Technical Support: sfb1002-support@gwdg.de
Department of Medical Informatics
University Medical Center Göttingen
Imprint
View: RUCDRi002-A-15 (Genetically Modified Cell Lines)
General
| hPSCreg Name | RUCDRi002-A-15 |
| Provider | University Medical Center Goettingen |
| Location | Stem Cell Unit |
| Cell Type | iPSC |
| Grade | Research |
| Related Cell Lines | RUCDRi002-A-34 RUCDRi002-A-35 RUCDRi002-A-47 RUCDRi002-A-48 |
| Is the cell line readily obtainable for third parties? | Yes |
| > Consent for research use? | Yes |
| > Consent for clinical use? | No |
| > Consent for commercial use? | No |
Editing
| Editing Strategy | knockin |
| Targeted Gene | AAVS1 CAG-dCas9-VPR-tdTomato |
| Editing Method | CRISPR | protein | nucleofection |
Miscellaneous
| Contact | laura.zelarayan@med.uni-goettingen.de |
Linked Publications
Combining a Tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC)Priesmeier L et al., 2023
